Hanx Biopharmaceuticals (Wuhan) Co Ltd

Company Profile

• Business description

  Hanx Biopharmaceuticals (Wuhan) Co Ltd is a biotech company with in-house capabilities in structural biology, translational medicine, and clinical development, focused on the development of immunotherapeutic products. Its product pipeline comprises one Core Product and nine other pipeline candidates, which are (i) three clinical stage drug candidates focused on oncology, including its Core Product HX009 and Key Products HX301 and HX044; and (ii) seven preclinical stage drug candidates including antibody drug conjugate, bispecific antibody and monoclonal antibody for both autoimmune and oncology markets.

• Contact

  No. 1 Jiufeng 1st Road
  Building A8, Phase II, Bio-Innovation Park
  East Lake New Technology Development Zone
  Hubei
  Wuhan
  CHN

  T: +86 2765524978

  http://www.hanxbio.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 December 2026

  Employees

  55